DEPARTMENT OF BIOTECHNOLOGY SUPPORTED NATIONAL FACILITY AT VENTURE CENTER, PUNE NOW OPEN FOR OPERATIONS
CBA will provide high-quality analytical services for biopharmaceutical developers and manufacturers
The Center for Biopharma Analysis (CBA) supported by the National Biopharma Mission (NBM) of Department of Biotechnology (DBT)- Biotechnology Industry Research Assistance Council (BIRAC) at Pune-based technology business incubator, Venture Center was inaugurated virtually by Secretary, DBT, Dr Renu Swarup.
CBA will provide high-quality analytical services for biopharmaceutical developers and manufacturers. This center is envisioned to become a resource center for structural and functional characterization of biologicals and biopharmaceuticals that will create long lasting value for bioentrepreneurs and industry.
மத்திய உயிரி தொழில்நுட்பத்துறையின் ஆதரவுடன் கூடிய புனேவில் உள்ள வென்ச்சர் மையம் தேசிய வசதி இப்போது செயல்பாடுகளுக்கு திறக்கப்பட்டுள்ளது
Inaugurating the facility via video conference, Dr Renu Swarup, Secretary, DBT, said that she expects that the CBA will play a pivotal role in supporting biopharma innovations from academic and government research labs, startups and many Indian companies with not only high-quality analytical characterization but also advise on studies needed for regulatory approvals. This can help speed up the development process.
Also speaking on the occasion, Prof AK Nangia, Director, CSIR-NCL highlighted how NCL is keen to contribute to the large molecule therapeutics revolution waiting to happen in India as it did for small molecule therapeutics in 1970-80s. Mr Prasanta Biswal, CEO of International Biotech Park Limited, Pune said that IBPL is happy to have contributed CSR support for the CBA infrastructure development and looks forward to working closely with Venture Center and BIRAC in positioning the Pune Knowledge Cluster for excellence in biopharma and medtech development and manufacturing.